Sarepta Therapeutics to Present at the Credit Suisse 28th Annual Healthcare Conference

Date : 11/05/2019 @ 9:30PM
Source : GlobeNewswire Inc.
Stock : Sarepta Therapeutics Inc New (SRPT)
Quote : 123.98  0.89 (0.72%) @ 5:00AM
After Hours
Last Trade
Last $ 124.30 ▲ 0.32 (0.26%)

Sarepta Therapeutics to Present at the Credit Suisse 28th Annual Healthcare Conference

Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart

6 Months : From Aug 2019 to Feb 2020

Click Here for more Sarepta Therapeutics Charts.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the Credit Suisse 28th Annual Healthcare Conference on Tuesday, Nov. 12, 2019 at 11:10 a.m. E.T. / 9:10 a.m. M.T. The fireside chat will be held at the at The Phoenician in Scottsdale, Ariz.

The presentation will be webcast live under the investor relations section of Sarepta’s website at and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta TherapeuticsSarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in gene therapies for Limb-girdle muscular dystrophy diseases (LGMD), MPS IIIA, Pompe and other CNS-related disorders, totaling over 20 therapies in various stages of development. The Company’s programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is fueled by an audacious but important mission: to profoundly improve and extend the lives of patients with rare genetic-based diseases. For more information, please visit

Internet Posting of InformationWe routinely post information that may be important to investors in the 'For Investors' section of our website at We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.Investors: Ian Estepan, 617-274-4052

Media:Tracy Sorrentino,

Latest SRPT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.